White & Case advises on sale of Icade's stake in Icade Santé to Primonial REIM
1 min read
Global law firm White & Case LLP has advised healthcare property investor Icade Santé and its minority shareholders Predica, Sogecap and BNP Paribas Cardif on the sale of Icade's stake in Icade Santé to European real estate asset management platform Primonial REIM.
The first stage of the transaction, expected to complete by the end of July 2023, is the sale of approximately 64 percent of Icade's stake in Icade Santé for €1.4 billion. Icade's remaining stake in Icade Santé is expected to be sold by the end of 2025, mainly to funds managed by Primonial REIM or to investors identified by Primonial REIM. The transaction is subject to employee consultation processes.
The White & Case team in Paris which advised Icade Santé on the transaction was led by partners Thomas Le Vert and Jean Paszkudzki and included partners Raphaël Richard, Brice Engel and Alexandre Jaurett, counsel Michel Courtois and associates Boris Kreiss, Hugo Chevillot, Chloé Bouffard and Cécilia Grosjean. The White & Case team in Paris which advised the minority shareholders Predica, Sogecap and Cardif was led by partner Nathalie Nègre-Eveillard and included associate Emmanuel Chevignon.
For more information please speak to your local media contact.